A
Participants and Invited Experts Between December 1, 2004, and June 27, 2005

Participants

December 1, 2004


Alan Breier

Vice President, Medical, and Chief Medical Officer

Eli Lilly and Company


Catherine D.DeAngelis

Editor-in-Chief

Journal of the American Medical Association


Jeffrey M.Drazen

Editor-in-Chief

New England Journal of Medicine


Lawrence Hirsch

Executive Director, Medical Communications

Merck Research Laboratories


Richard Kingham

Partner

Covington & Burling


Ronald Krall

Senior Vice President, World Wide Development, GlaxoSmithKline Pharmaceuticals


Alexa McCray

Director, Lister Hill National Center for Biomedical Communications

National Library of Medicine


Lana Skirboll (via phone)

Associate Director of Science Policy

Office of the Director

National Institutes of Health


Harold C.Sox

Editor

Annals of Internal Medicine


Melvyn L.Sterling

Chair, Council on Scientific Affairs

American Medical Association


Robert Temple (via phone)

Director, Office of Medical Policy

Center for Drug Evaluation and Research

U.S. Food and Drug Administration


Elias Zerhouni (via phone)

Director

National Institutes of Health



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement



Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 49
Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Summary A Participants and Invited Experts Between December 1, 2004, and June 27, 2005 Participants December 1, 2004 Alan Breier Vice President, Medical, and Chief Medical Officer Eli Lilly and Company Catherine D.DeAngelis Editor-in-Chief Journal of the American Medical Association Jeffrey M.Drazen Editor-in-Chief New England Journal of Medicine Lawrence Hirsch Executive Director, Medical Communications Merck Research Laboratories Richard Kingham Partner Covington & Burling Ronald Krall Senior Vice President, World Wide Development, GlaxoSmithKline Pharmaceuticals Alexa McCray Director, Lister Hill National Center for Biomedical Communications National Library of Medicine Lana Skirboll (via phone) Associate Director of Science Policy Office of the Director National Institutes of Health Harold C.Sox Editor Annals of Internal Medicine Melvyn L.Sterling Chair, Council on Scientific Affairs American Medical Association Robert Temple (via phone) Director, Office of Medical Policy Center for Drug Evaluation and Research U.S. Food and Drug Administration Elias Zerhouni (via phone) Director National Institutes of Health

OCR for page 49
Developing a National Registry of Pharmacologic and Biologic Clinical Trials: Workshop Summary Invited Experts Between December 1, 2004, and June 27, 2005 Alan Breier Vice President, Medical and Chief Medical Officer Eli Lilly and Company Catherine D.DeAngelis Editor-in-Chief Journal of the American Medical Association Jeffrey M.Drazen Editor-in-Chief New England Journal of Medicine Lawrence Hirsch Executive Director, Medical Communications Merck Research Laboratories John Hoey Editor Canadian Medical Association Journal Christine Laine Executive Secretary Annals of Internal Medicine Justin McCarthy General Counsel, Pfizer Global Research and Development Pfizer, Inc. Frank Rockhold Senior Vice President and Director, Biomedical Data Sciences GlaxoSmithKline Pharmaceuticals Research and Development Alfred Sandrock Vice President, Medical Research-Neurology Biogen Idec Ralph Smalling Vice President, Global Research and Development Policy Analysis Amgen Harold Sox Editor Annals of Internal Medicine